Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
33 studies found for:    " November 12, 2008":" December 12, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" November 12, 2008":" December 12, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Seroprevalence of HSV-2 in HIV Infected Subjects and the Effect of Daily Valacyclovir in the Reduction of HSV-2 Recurrence and Viral Shedding
Conditions: HSV-2;   HIV;   HIV Infections
Interventions: Drug: Valacyclovir;   Drug: Placebo
2 Completed Impact of Different Contraceptives on the Immune System of HIV Infected Women in Zambia
Conditions: HIV;   Contraception;   HIV Infections
Interventions: Drug: Depo Provera;   Device: Copper T Intrauterine contraception device
3 Unknown  Topical Cyclosporine for the Treatment of Dry Eye in Patients Infected With the Human Immunodeficiency Virus
Conditions: Dry Eye Syndromes;   HIV Seropositivity
Interventions: Drug: cyclosporine and sodium carboximethycellulose;   Drug: sodium carboximethycellulose
4 Completed Effect Of An Integrase Inhibitor On The Latency And Reservoir Of HIV-1
Conditions: HIV-1;   HIV Infections
Intervention: Drug: Raltegravir
5 Completed
Has Results
Human Immunodeficiency Virus (HIV), Arterial Dysfunction, Lipids, Lovaza (HALO) Trial
Conditions: Cardiovascular Disease;   HIV Infection
Interventions: Drug: Lovaza;   Drug: Placebo
6 Completed Mupirocin Ointment to Eliminate Nasal Carriage of Staphylococcus Aureus in HIV Infection
Conditions: Staphylococcus Aureus;   HIV Infections
Interventions: Drug: Mupirocin calcium ointment, 2%;   Drug: Placebo ointment
7 Completed Safety and Immune Response to Preventive HIV Immunization With Adenovirus Serotype 5 or 35 Vector
Condition: HIV Infections
Interventions: Biological: DNA Vaccine;   Biological: DNA Vaccine placebo;   Biological: rAd35;   Biological: rAd35 placebo;   Biological: rAd5;   Biological: rAd5 placebo
8 Active, not recruiting Micronutrients and Antioxidants in HIV Infection
Condition: HIV Infection
Interventions: Dietary Supplement: Micronutrients and antioxidants;   Dietary Supplement: Multivitamins and minerals
9 Completed Efficacy of Treatment Intensification With Maraviroc on HIV-1 Viral Latency in Recently Infected Hiv-1 naïve Patients Starting Raltegravir Plus Tenofovir/Emtricitabine
Condition: HIV Infections
Interventions: Drug: Raltegravir;   Drug: Maraviroc;   Drug: Tenofovir/Emtricitabine
10 Recruiting Antiretroviral Therapy for Acute HIV Infection
Condition: Acute HIV Infection
Interventions: Drug: HAART;   Drug: Mega-HAART
11 Unknown  Efficacy and Safety of MK-0518 in Treatment-Experienced HIV-1 Infected Adult Patients With Hemophilia
Conditions: HIV Infection;   Hemophilia A
Intervention:
12 Completed Examination of B Cell Responses in Human Blood
Condition: HIV Infections
Intervention:
13 Completed Cognitive Behavioral Treatment to Reduce Alcohol Use Among HIV-Infected Kenyans
Conditions: Binge Drinking;   Alcohol Abuse;   Alcohol Dependence;   HIV Infections
Interventions: Behavioral: HIV support group;   Behavioral: CBT
14 Completed Efficacy And Security Of Annual And Biennial Zoledronic Acid For Osteoporosis Treatment In An HIV-Infected Patients' Cohort
Condition: HIV Infections
Interventions: Drug: Zoledronic acid;   Behavioral: Lifestyle modifications
15 Active, not recruiting
Has Results
An Open Label Pharmacokinetic, Safety And Efficacy Study Of Maraviroc In Combination With Background Therapy For The Treatment Of HIV-1 Infected, CCR5 -Tropic Children
Condition: Human Immunodeficiency Virus (HIV)
Intervention: Drug: Maraviroc
16 Completed A Phase I Study of Quadrivalent Human Papilloma Virus (HPV) (Types 6, 11, 16, 18) Recombinant Vaccine in HIV-Infected and HIV-Negative Pre-Adolescents, Adolescents, and Young Adults
Conditions: Human Immunodeficiency Virus;   Human Papillomavirus- 6, 11, 16, 18;   Adolescent;   Papillomavirus Vaccines
Interventions: Biological: Gardisil;   Behavioral: Survey
17 Completed A Feasibility Study of Co-administering Combination Antiretroviral Therapy (cART) and R-EPOCH Chemotherapy for the Management of ARL
Conditions: Lymphoma, AIDS Related;   HIV Infections
Intervention: Drug: R-EPOCH and cART
18 Recruiting Establish and Characterize an Acute HIV Infection Cohort in a High Risk Population
Condition: Acute HIV Infection
Intervention:
19 Completed Efavirenz (EFV) in HIV-Infected and HIV/Tuberculosis (TB) Coinfected Children
Conditions: HIV Infections;   Tuberculosis
Interventions: Drug: Efavirenz (EFV);   Drug: Rifampin-containing anti-TB therapy
20 Completed Vaccination of HIV-1 Infected Patients With Dendritic Cells in Addition to Antiretroviral Treatment - (DALIA Trial)
Condition: HIV
Intervention: Biological: Dendritic Cell Vaccine

   Previous Page Studies Shown (1-20) Next Page (21-33) Show next page of results    Last Page
Indicates status has not been verified in more than two years